Block 2 Lecture 6/7 -- Transplant Flashcards
MoA of OKT3
Anti-TCR (anti-CD3)
MoA of CTLA4-Ig
anti-costimulatory
MoA of basiliximab
anti-IL-2R
MoA of daclizumab
anti-IL-2R
MoA of rapamycin
interferes with mTOR signaling
– reduces proliferation
MoA of cyclosporine
inhibits calcineurin
– interferes with NF-AT mediated cytokine transcription (IL-2)
MoA of FK506/tacrolimus
inhibits calcineurin
– interferes with NF-AT mediated cytokine transcription (IL-2)
MoA of azathioprine
anti-proliferator blocks B/T cell synthesis
MoA of mycophenolate
anti-proliferator blocks B/T cell synthesis
MoA of corticosteroids
1) anti-inflammatory: inhibit m0 cytokine synthesis
2) blocks T cell activation
MoA of thymoglobulin
anti-tcr
MoA of atgam
anti-tcr
What agents are used in induction immunosuppression?
1) anti-TCR
2) anti-IL-2R
3) alemtuzumab
MoA of alemtuzumab
targets CD52
What drugs are used in maintenance immunosuppression?
1) calcineurin inhibitors
2) anti-proliferators
3) +/- corticosteroids
How is hyperacute rejection mediated?
self-Ab-mediated (against blood or graft)
How is acute rejection mediated?
allo-Ag-specific CD4/8 T-cell-mediated
How is chronic rejection mediated?
CD4-cytokine mediated
endothelium recognizes cytokines
Results of hyperacute rejection:
1) complement activation
2) endothelial damage
3) inflammation
4) thrombosis
Results of acute rejection:
1) parenchymal cell damage
2) interstitial inflammation
3) endothelialitis
Results of chronic rejection:
1) chronic inflammatory reaction in vasculature walls
2) intimal smooth muscle cell proliferation
3) vessel occlusion
What is direct antigen presentation?
allo/donor-APC presents self-Ag to T-cell
– T cell recognizes allo-MHC as foreign